Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 AbobotulinumtoxinA 💬[1] Botulinum toxin type A[5] Botulinum toxin A; Botulinum toxin type A; IncobotulinumtoxinA; Onabotulinumtoxin A; OnabotulinumtoxinA--[13] 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
2 Anakinra 💬[1] Anakinra[1] ANAKINRA[2] IL1R1,
IL1R2 💬 		[15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[22] 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
3 Baclofen 💬[1] Baclofen[1] BACLOFEN[2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[8] 2, 10, 13, 18, 65, 70, 149, 206 💬
4 Botulinum toxin type A 💬[1] Botulinum toxin type A[5] Botulinum toxin A; BOTULINUM TOXIN TYPE A; IncobotulinumtoxinA; Onabotulinumtoxin A; OnabotulinumtoxinA[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[13] 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
5 Brivaracetam 💬[1] Brivaracetam[1] BRIVARACETAM[1] SV2A 💬 [1] ECM-receptor interaction 💬[2] 149, 309 💬
6 Ezetimibe 💬[1] Ezetimibe[1] Ezetimibe[1] NPC1L1 💬 [1] Fat digestion and absorption 💬[5] 49, 79, 93, 149, 260 💬
7 Fenfluramine 💬[1] Fenfluramine[2] Fenfluramine; Fenfluramine hydrochloride[5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		[11] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[6] 140, 143, 144, 145, 149, 156 💬
8 Fenfluramine hydrochloride 💬[1] Fenfluramine[2] Fenfluramine; FENFLURAMINE HYDROCHLORIDE[5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		[11] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[6] 140, 143, 144, 145, 149, 156 💬
9 Incobotulinumtoxin A 💬[1] Botulinum toxin type A[5] Botulinum toxin A; BOTULINUM TOXIN TYPE A; IncobotulinumtoxinA; Onabotulinumtoxin A; OnabotulinumtoxinA[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[13] 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
10 Lacosamide 💬[1] Lacosamide[1] Lacosamide[2] SCN3A,
SCN9A 💬 		[1] Taste transduction 💬[4] 2, 46, 149, 298 💬
11 Levetiracetam 💬[1] Levetiracetam[1] Levetiracetam[1] SV2A 💬 [1] ECM-receptor interaction 💬[7] 2, 4, 6, 13, 34, 149, 307 💬
12 Melatonin 💬[1] Melatonin[1] Melatonin[2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[18] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
13 OnabotulinumtoxinA 💬[1] Botulinum toxin type A[5] Botulinum toxin A; BOTULINUM TOXIN TYPE A; IncobotulinumtoxinA; Onabotulinumtoxin A; OnabotulinumtoxinA--[13] 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
14 Oxygen 💬[1] Oxygen[1] Oxygen--[30] 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
15 Padsevonil 💬[1] Padsevonil[1] Padsevonil[3] SV2A,
SV2B,
SV2C 💬 		[1] ECM-receptor interaction 💬[1] 149 💬
16 Psilocybin 💬[1] Psilocybin[2] Psilocybin; Psilocybine[1] HTR2A 💬 [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[5] 2, 6, 13, 149, 206 💬
17 Sodium oxybate 💬[1] Sodium oxybate[1] Sodium Oxybate--[2] 6, 149 💬
18 Tocilizumab 💬[1] Tocilizumab[2] BAT1806; TOCILIZUMAB[1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[26] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
19 Triheptanoin 💬[1] Triheptanoin[1] TRIHEPTANOIN--[12] 2, 8, 65, 149, 156, 248, 256, 257, 317, 318, 324, 344 💬